EBR Systems, Inc. Initiates Global Trial of World’s Only Wireless CRT Pacing Technology

SUNNYVALE, Calif.–(BUSINESS WIRE)–EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced enrollment of the first patients in the global SOLVE-CRT (Stimulation of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy) clinical trial. The first patients were enrolled by Prof. Dr. Christian Butter […]

Cardiac Insight, Inc. to Showcase Wearable Devices and Systems for Atrial Fibrillation and Sudden Cardiac Death Risk Detection at the American College of Cardiology’s 67th Annual Scientific Session, March 10-12, Booth #2417

KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a leading U.S. developer of wearable medical devices and diagnostic software, announced today the company will showcase its one-of-a-kind cardiac devices and software systems, featuring proprietary algorithms, for the first time at a major cardiology exposition at the annual American College of Cardiology’s (ACC) 67th Annual […]

Nihon Kohden Launches Aireeg® WEE-1200 Wireless EEG System at HIMSS18

IRVINE, Calif.–(BUSINESS WIRE)– Nihon Kohden Corporation, a U.S. market leader in precision medical products and services, has launched its aireeg®WEE-1200 wireless electroencephalogram (EEG) system designed specifically for patient comfort and easy access to real-time patient data during long-term epilepsy monitoring, intensive care, and routine EEG environments. The smart, safe and secure […]

Safety and Effectiveness of BioTrace Medical’s Tempo® Lead Further Demonstrated in Multi-Center Analysis of More Than 200 Cardiac Procedures

MENLO PARK, Calif. & ORLANDO, Fla.–(BUSINESS WIRE)–BioTrace Medical, Inc., the leader in innovative temporary pacing technology, today announced positive safety and effectiveness data from a physician-sponsored U.S. study of the company’s Tempo® Temporary Pacing Lead. Results from a multi-center retrospective analysis of 224 U.S. interventional cardiac procedures, including transcatheter aortic valve […]

Results of Landmark Wearable Defibrillator Trial to Be Presented as ACC.18 Late-Breaker

CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that findings from the “Vest Prevention of Early Sudden Death Trial” (VEST Trial) on use of the ZOLL LifeVest® wearable cardioverter defibrillator (WCD) will be presented as a Late-Breaking Clinical Trial at the American […]

CardioFocus Announces Intiation of HeartLight® X3 Clinical Evaluation

MARLBOROUGH, Mass., Feb. 26, 2018 /PRNewswire/ — CardioFocus, Inc., a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AF), today announced the initiation of a clinical evaluation of the new HeartLight X3 System for the treatment of AF. Building upon the advanced features of the […]

Texas Cardiac Arrhythmia Institute at St. David’s Medical Center to host EPLive 2018

AUSTIN, Texas, Feb. 26, 2018 /PRNewswire/ — On March 1 and 2, 2018, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center will host its fourth international symposium on complex arrhythmias, EPLive 2018. EPLive is an intensive, two-day educational meeting for practicing clinical cardiac electrophysiologists, electrophysiologist fellows and […]

Cardiva Medical Brings Total Financing Round to $41 Million; Announces Sponsorship of AMBULATE Trial, First Vascular Closure Trial Targeted at High Growth Electrophysiology Procedures

New Vascular Closure Device for Multi-Access Mid-Bore Vein Procedures, Specifically Cardiac Ablation, Aims to Reduce Time to Ambulation and Improve the Patient Experience SANTA CLARA, Calif.–(BUSINESS WIRE)– Cardiva Medical ®, an innovator in the field of vascular closure, today announced that the company has closed on $11 million in additional financing – […]

CRM Devices Market Size Worth $32.4 Billion By 2025 | CAGR: 7.8%: Grand View Research, Inc.

SAN FRANCISCO, February 19, 2018 /PRNewswire/ — The global cardiac rhythm management (CRM) devices market size is anticipated to reach USD 32.4 billion by 2025, according to a new report by Grand View Research, Inc., registering a 7.8% CAGR during the forecast period. Increase in demand for CRM devices can be attributed to supportive legislative policies […]

Cardiac Insight, Inc. Welcomes Renowned Atrial Fibrillation Cardiologists Professor John Camm and Albert L. Waldo, MD to its Scientific Advisory Board

KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a leading U.S. developer of wearable medical devices and diagnostic software, announced today the company continues to garner global interest in its approach to cardiac care, and has added renowned cardiologists and atrial fibrillation (AFib) specialists, Professor John Camm and Albert L. Waldo, MD, PhD […]